Government Affairs
Refine Search
Pharmaceutical
The European Commission has proposed 100 billion euros ($118 billion) for research and innovation as part of the Horizon Europe program. 7 June 2018
Pharmaceutical
The world’s first fully-automated drug discovery facility is to be built in Oxfordshire, UK. 6 June 2018
Pharmaceutical
British charity Meningitis Now has issued a statement criticising a government report on vaccine cost effectiveness, saying it represents “a significant threat to the future of the UK’s lifesaving meningitis vaccine program.” 6 June 2018
Pharmaceutical
The Russian national Parliament (State Duma), together with the government, will suspend introducing a ban on the imports of drugs from the USA and other ‘unfriendly’ Western states by at least the end of the current year, according to recent statements of some senior officials in the Russian government, including the Russian Health Minister Veronika Skvortsova, report The Pharma Letter’s local correspondent. 5 June 2018
Pharmaceutical
A strongly-worded editorial in the British Medical Journal (BMJ) has called on healthcare professionals to stand up and highlight what it calls the ‘risks of Brexit to our health and our health services’. 29 May 2018
Generics
Several European countries — including Ireland, Italy and Portugal — have been singled out by the European Commission over inefficiencies in their healthcare services as part of the European Union's annual semester reports. 25 May 2018
Pharmaceutical
After several failed congressional attempts to meet US President Donald Trump’s request for a so-called ‘right to try’ bill earlier this year, lawmakers have finally succeeded in delivering legislation for him to sign. 24 May 2018
Pharmaceutical
The importance of the UK to Eli Lilly as both an operations base and a market has been made evident by the US pharma company’s commissioning of a new report with the Confederation of British Industry. 22 May 2018
Pharmaceutical
In our latest Special Report, Ali Hansford, head of social policy at the Association of the British Pharmaceutical Industry (ABPI), discusses the UK government's plans to invest £20 million ($27 million) more into the research, diagnosis and development of brain tumor treatments. She reflects on the work of pharma globally in this field. 18 May 2018
Pharmaceutical
Giuseppe Sala, Mayor of the city of Milan, Italy, participated in a hearing before the Committee on Petitions of the European Parliament this week to clarify some elements of the relocation process of the European Medicines Agency (EMA) following the exit of the UK from the European Union. 18 May 2018
Pharmaceutical
For the 14th consecutive year, the USTR has put China on a ‘priority watch list' on its annual analysis of countries’ adherence to standards governing intellectual property rights. 17 May 2018
Pharmaceutical
The Drugs Controller General of India (DCGI) and the Indian Council of Medical Research (ICMR) have come under fire for approving the human papillomavirus (HPV) vaccine for cervical cancer patients, despite a report by India's Parliament opposing its use. The government, meantime, continues to dither over introducing the HPV vaccine in its Universal Immunization Program, reports The Pharma Letter’s India correspondent. 10 May 2018
Pharmaceutical
Australia’s Federal Budget has revealed a comprehensive plan for ‘better targeting the research and development tax incentive’ (R&DTI). 9 May 2018
Pharmaceutical
Following the re-election of Hungary’s Viktor Orbán as prime minister, the country’s leading pharma trade group has issued a summary of what it says are the most urgent priorities concerning the Hungarian pharmaceutical industry. 8 May 2018
Biotechnology
Ahead of the Australian Federal Budget, Chris Nave, chief executive of the Medical Research Commercialization Fund and Managing Director at the venture capital firm Brandon Capital, shares his thoughts on the promising landscape of Australian biotech. 4 May 2018
Biotechnology
A report commissioned by AstraZeneca has explored the value of life sciences clusters to the UK economy. 4 May 2018
Pharmaceutical
Talking at the World Health Care Congress on Wednesday, Health and Human Services (HHS) Secretary Alex Azar reportedly said the White House would go “much further” than budget proposals to challenge high drug prices. 3 May 2018
Biotechnology
The lead developer of drugs for cystic fibrosis (CF) is under pressure to slash the price of Orkambi (lumacaftor/ivacaftor), the first drug directed at treating the cause of the disease in people who have two copies of the F508del mutation, accounting for around 45% of cases. 30 April 2018
Pharmaceutical
The UK Minister for Intellectual Property, Sam Gyimah MP, on Thursday (April 26) confirmed that the UK has ratified the Unified Patent Court Agreement (UPCA). 27 April 2018
Pharmaceutical
The Russian national Parliament (State Duma) plans to consider the possibility of introducing a ban on the imports of drugs from the USA and some European Union states to Russia at the beginning of the current year, according to Duma press-service. 25 April 2018
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze